🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST

Aytu BioPharma Balance Sheet

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
25.4926.3130.9520.0122.9919.36
Cash & Short-Term Investments
25.4926.3130.9520.0122.9919.36
Cash Growth
-21.87%-15.00%54.71%-12.96%18.72%-61.01%
Receivables
20.3322.7831.1623.5328.7321.71
Inventory
6.026.8611.4312.148.5110.85
Prepaid Expenses
5.315.815.645.15.437.38
Other Current Assets
---1.125.430.63
Total Current Assets
57.1661.7679.1861.8971.0859.93
Property, Plant & Equipment
1.161.241.591.523.616.3
Other Intangible Assets
40.3241.442.252.4557.4470.63
Long-Term Deferred Tax Assets
-0.20.250.761.38-
Other Long-Term Assets
0.540.40.951.472.960.77
Total Assets
99.17105.01124.18118.1136.46137.62

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
11.5111.2810.610.3112.5510.99
Accrued Expenses
33.7114.1815.2622.2624.5425.71
Short-Term Debt
66.079.062.41.563.81
Current Portion of Long-Term Debt
1.861.861.861.86--
Current Portion of Leases
-0.220.140.711.340.1
Other Current Liabilities
0.2621.0426.1524.6929.0223.84
Total Current Liabilities
53.3354.6663.0662.2369.0264.44
Long-Term Debt
8.659.110.910.8814.7114.2
Long-Term Leases
-0.850.990.580.830.08
Long-Term Deferred Tax Liabilities
-0.20.250.761.38-
Other Long-Term Liabilities
5.634.9230.0215.9411.1714.59
Total Liabilities
67.6169.73105.2190.3897.1193.32

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
00000-
Additional Paid-In Capital
383.23383.06352.5347.69343.49331.39
Retained Earnings
-351.67-347.79-333.54-319.97-304.13-287.08
Total Common Equity
31.5635.2718.9727.7239.3644.31
Shareholders' Equity
31.5635.2718.9727.7239.3644.31
Total Liabilities & Equity
99.17105.01124.18118.1136.46137.62

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
16.5118.1122.9416.4218.4518.19
Net Cash (Debt)
8.998.28.023.594.531.17
Net Cash Growth
112.51%2.33%123.38%-20.87%286.86%-95.29%
Net Cash Per Share
0.610.671.280.651.360.80
Filing Date Shares Outstanding
10.8710.879.916.175.533.12
Total Common Shares Outstanding
10.8710.738.985.975.521.93
Working Capital
3.847.116.12-0.342.06-4.51
Book Value Per Share
2.903.292.114.647.1322.97
Tangible Book Value
-8.75-6.13-23.24-24.74-18.08-26.32
Tangible Book Value Per Share
-0.81-0.57-2.59-4.14-3.28-13.65
Machinery
-1.031.082.784.294.45
Construction In Progress
----0.11-
Leasehold Improvements
-0.160.160.0411
SEC Filings: 10-K · 10-Q